190 related articles for article (PubMed ID: 22728221)
1. Immunization of newborns with bacterial conjugate vaccines.
van den Biggelaar AH; Pomat WS
Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221
[TBL] [Abstract][Full Text] [Related]
2. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
3. Protein conjugate vaccines--how much is enough?
Obaro SK
Trends Microbiol; 2001 Aug; 9(8):364-5. PubMed ID: 11519529
[No Abstract] [Full Text] [Related]
4. The promise of conjugate vaccines for Africa.
Kieny MP; LaForce FM
Vaccine; 2007 Sep; 25 Suppl 1():A108-10. PubMed ID: 17548136
[TBL] [Abstract][Full Text] [Related]
5. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
6. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
[TBL] [Abstract][Full Text] [Related]
7. Conjugated polysaccharide vaccines.
Ahmad H; Chapnick EK
Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in bacterial conjugate vaccines.
Goldblatt D
J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
[TBL] [Abstract][Full Text] [Related]
9. Conjugate vaccines--a breakthrough in vaccine development.
Mäkelä PH
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
[TBL] [Abstract][Full Text] [Related]
10. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of bacterial meningitis.
Peltola H
Infect Dis Clin North Am; 1999 Sep; 13(3):685-710, viii. PubMed ID: 10470562
[TBL] [Abstract][Full Text] [Related]
12. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
Pollard AJ; Perrett KP; Beverley PC
Nat Rev Immunol; 2009 Mar; 9(3):213-20. PubMed ID: 19214194
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of pneumococcal conjugate vaccines.
Eskola J
Pediatr Infect Dis J; 2000 Apr; 19(4):388-93. PubMed ID: 10783041
[TBL] [Abstract][Full Text] [Related]
16. Evolution of conjugate vaccines.
Mäkelä PH; Käyhty H
Expert Rev Vaccines; 2002 Oct; 1(3):399-410. PubMed ID: 12901578
[TBL] [Abstract][Full Text] [Related]
17. [Conjugated vaccines].
Fritzell B
Therapie; 2005; 60(3):249-55. PubMed ID: 16128267
[TBL] [Abstract][Full Text] [Related]
18. Use of conjugate vaccines to prevent meningitis caused by Haemophilus influenzae type b or Streptococcus pneumoniae.
Eskola J
J Hosp Infect; 1995 Jun; 30 Suppl():313-21. PubMed ID: 7560967
[TBL] [Abstract][Full Text] [Related]
19. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
20. Designing meningitis vaccines.
Buttery JP; Moxon ER
J R Coll Physicians Lond; 2000; 34(2):163-8. PubMed ID: 10816873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
